Plant-derived EpCAM antigen induces protective anti-cancer response

Immunotherapy holds great promise for treatment of infectious and malignant diseases and might help to prevent the occurrence and recurrence of cancer. We produced a plant-derived tumor-associated colorectal cancer antigen EpCAM (pGA733) at high yields using two modern plant expression systems. The...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Immunology, Immunotherapy Vol. 57; no. 3; pp. 317 - 323
Main Authors: Brodzik, Robert, Spitsin, Sergei, Golovkin, Max, Bandurska, Katarzyna, Portocarrero, Carla, Okulicz, Monika, Steplewski, Zenon, Koprowski, Hilary
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer-Verlag 01-03-2008
Springer
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immunotherapy holds great promise for treatment of infectious and malignant diseases and might help to prevent the occurrence and recurrence of cancer. We produced a plant-derived tumor-associated colorectal cancer antigen EpCAM (pGA733) at high yields using two modern plant expression systems. The full antigenic domain of EpCAM was efficiently purified to confirm its antigenic and immunogenic properties as compared to those of the antigen expressed in the baculovirus system (bGA733). Recombinant plant-derived antigen induced a humoral immune response in BALB/c mice. Sera from those mice efficiently inhibited the growth of SW948 colorectal carcinoma cells xenografted in nude mice, as compared to the EpCAM-specific mAb CO17-1A. Our results support the feasibility of producing anti-cancer recombinant vaccines using plant expression systems.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0340-7004
1432-0851
DOI:10.1007/s00262-007-0366-4